glp 1 and gallbladder disease GLP-1 Medications Health: What You Should Know GLP-1 and Gut Health: Addressing

Role of b cells and antibodies in multiple sclerosis

The market has seen strong traction from newer therapies such as: Eli Lillys Mounjaro (tirzepatide), launched in the UK in February 2024 and made available via the NHS in March 2025 Novo Nordisks Wegovy (semaglutide), introduced in the UK in September 2023 through specialist NHS weight-management services While these newer molecules dominate headlines, liraglutide remains a widely prescribed and proven therapy, and Biocons entry offers a more affordable alternativea key differentiator in public healthcare systems

10.2174/1875037000902010038 Open Gene Ther

Its probably something more around this GLP-1 receptor recognition, she said

If you're pregnant or breastfeeding, we recommend waiting - there just isn't enough safety data yet